Summary
Becton Dickinson and Company (BDX) filed a Form 8-K on June 13, 2003, to disclose a transaction involving a key executive. William A. Kozy, President of BD Clinical Laboratory Solutions and Company Operations, exercised stock options on June 5, 2003. This transaction involved the exercise of options for 4,988 shares, with the exercise price paid for by delivering 2,494 existing BDX shares. Following this option exercise and share delivery, Mr. Kozy's total beneficial ownership of BDX shares increased to 40,147 from 37,657. This filing is primarily for informational purposes under Regulation FD, highlighting a change in insider holdings. Investors should note this is a disclosure of an executive's personal investment activity rather than a material business event.
Key Highlights
- 1Disclosure of a stock option exercise by a senior executive, William A. Kozy.
- 2Transaction occurred on June 5, 2003, and was reported on June 13, 2003.
- 3Mr. Kozy exercised options for 4,988 shares.
- 4Payment for the exercise was made using 2,494 BDX shares.
- 5Mr. Kozy's total beneficial ownership of BDX shares increased to 40,147.
- 6The filing falls under Regulation FD, ensuring public disclosure of material information.
- 7No other material business events or financial updates were reported in this 8-K.